BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36112984)

  • 1. Depression, Anxiety, and Their Association to Health-Related Quality of Life in Men Commencing Prostate Cancer Treatment at Tertiary Hospitals in Cape Town, South Africa.
    Irusen H; Fernandez P; Van der Merwe A; Suliman S; Esterhuizen T; Lazarus J; Parkes J; Seedat S
    Cancer Control; 2022; 29():10732748221125561. PubMed ID: 36112984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Related Anxiety in Men With Localized Prostate Cancer at Tertiary Hospitals in Cape Town, South Africa.
    Irusen H; Burger H; Fernandez PW; Esterhuizen T; Suliman S; Seedat S
    Cancer Control; 2021; 28():10732748211024239. PubMed ID: 34152224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with Prostate Cancer: Baseline Results from a Longitudinal Prospective Observational Study.
    Irusen H; Burger H; Fernandez PW; Van der Merwe A; Esterhuizen T; du Plessis DE; Seedat S
    Cancer Control; 2022; 29():10732748221082791. PubMed ID: 35442835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
    O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
    Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients.
    Arraras JI; Villafranca E; Arias de la Vega F; Romero P; Rico M; Vila M; Asín G; Chicata V; Domínguez MA; Lainez N; Manterola A; Martínez E; Martínez M
    Clin Transl Oncol; 2009 Mar; 11(3):160-4. PubMed ID: 19293053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
    Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
    J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study.
    Huang YT; Li CC; Chou YH; Ke HL; Chen CY
    Int J Clin Pharm; 2019 Aug; 41(4):993-1003. PubMed ID: 31240550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
    Lebret T; Culine S; Davin JL; Hennequin C; Mignard JP; Moreau JL; Rossi D; Zerbib M; Mahmoudi A; Latorzeff I
    Aging Male; 2014 Jun; 17(2):87-93. PubMed ID: 24576298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
    Adam S; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Rohrmann S; Brenner H; Arndt V
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13076. PubMed ID: 31050091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, anxiety, and depression in Turkish colorectal cancer patients.
    Alacacioglu A; Binicier O; Gungor O; Oztop I; Dirioz M; Yilmaz U
    Support Care Cancer; 2010 Apr; 18(4):417-21. PubMed ID: 19554353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
    Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
    Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring prostate cancer survivors' self-management behaviours and examining the mechanism effect that links coping and social support to health-related quality of life, anxiety and depression: a prospective longitudinal study.
    Paterson C; Robertson A; Nabi G
    Eur J Oncol Nurs; 2015 Apr; 19(2):120-8. PubMed ID: 25497067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
    Tombal B; Collins S; Morgans AK; Hunsche E; Brown B; Zhu E; Bossi A; Shore N
    Eur Urol; 2023 Dec; 84(6):579-587. PubMed ID: 37833178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
    Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
    Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study.
    Sharp L; O'Leary E; Kinnear H; Gavin A; Drummond FJ
    Psychooncology; 2016 Mar; 25(3):282-91. PubMed ID: 26249170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
    Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
    Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.